Celldex (CLDX)

Celldex (CLDX) – FDA

Apr 17, 2024 08:05 AM Celldex (CLDX) Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Feb 25, 2024 08:40 PM Celldex (CLDX) Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study
Nov 6, 2023 06:31 AM
Jun 12, 2023 05:27 AM
May 15, 2023 08:02 AM
Feb 27, 2023 05:46 AM
Dec 6, 2022 06:34 AM
Jul 1, 2022 05:48 AM
Jul 12, 2021 10:18 AM
Jun 4, 2021 09:01 AM
Jun 1, 2021 07:32 AM
Apr 12, 2021 04:01 PM
Mar 29, 2021 06:31 AM
Feb 22, 2021 04:02 PM
Dec 9, 2020 08:03 AM
Oct 13, 2020 08:03 AM
May 6, 2020 08:05 AM
Nov 18, 2019 08:06 AM
Nov 11, 2019 08:05 AM
Nov 8, 2019 07:36 AM
Apr 2, 2019 08:09 AM
Apr 1, 2019 01:01 PM
Nov 9, 2018 08:04 AM
Jun 4, 2018 06:59 AM
May 16, 2018 05:07 PM
Apr 20, 2018 08:07 AM
Apr 16, 2018 07:04 AM
Nov 30, 2017 08:02 AM
Nov 17, 2017 08:08 AM
Jun 5, 2017 04:28 PM
Jun 5, 2017 11:25 AM
Dec 5, 2016 08:03 AM
Oct 10, 2016 06:23 AM
Sep 28, 2016 08:33 AM
Jul 11, 2016 04:02 PM
Apr 20, 2016 08:35 AM
Apr 18, 2016 02:50 PM
Apr 18, 2016 09:08 AM
Mar 17, 2016 04:05 PM
Mar 7, 2016 11:31 AM
Mar 7, 2016 07:01 AM
Dec 8, 2015 09:01 AM
Nov 23, 2015 12:30 PM
Nov 20, 2015 02:35 PM
Jun 30, 2015 08:33 AM
Jun 29, 2015 09:21 AM
Jun 29, 2015 08:10 AM
Jun 1, 2015 06:28 AM
May 28, 2015 09:24 AM
Apr 30, 2015 09:42 AM